AU536854B2 - 1 1-dioxopenicillanoyl methyl penicillanate esters - Google Patents

1 1-dioxopenicillanoyl methyl penicillanate esters

Info

Publication number
AU536854B2
AU536854B2 AU13871/83A AU1387183A AU536854B2 AU 536854 B2 AU536854 B2 AU 536854B2 AU 13871/83 A AU13871/83 A AU 13871/83A AU 1387183 A AU1387183 A AU 1387183A AU 536854 B2 AU536854 B2 AU 536854B2
Authority
AU
Australia
Prior art keywords
dioxopenicillanoyl
esters
methyl penicillanate
penicillanate
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU13871/83A
Other languages
English (en)
Other versions
AU1387183A (en
Inventor
Wayne Ernest Barth
Vytautas John Jasys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Publication of AU1387183A publication Critical patent/AU1387183A/en
Application granted granted Critical
Publication of AU536854B2 publication Critical patent/AU536854B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU13871/83A 1982-04-23 1983-04-22 1 1-dioxopenicillanoyl methyl penicillanate esters Expired AU536854B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin
US371156 1982-04-23

Publications (2)

Publication Number Publication Date
AU1387183A AU1387183A (en) 1983-11-17
AU536854B2 true AU536854B2 (en) 1984-05-24

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13871/83A Expired AU536854B2 (en) 1982-04-23 1983-04-22 1 1-dioxopenicillanoyl methyl penicillanate esters

Country Status (27)

Country Link
US (1) US4432987A (2)
EP (1) EP0092968B1 (2)
JP (1) JPS58201792A (2)
KR (1) KR860001279B1 (2)
AU (1) AU536854B2 (2)
CA (1) CA1187484A (2)
CS (1) CS235320B2 (2)
DD (1) DD209632A5 (2)
DE (1) DE3362502D1 (2)
DK (1) DK162168C (2)
EG (1) EG16412A (2)
ES (1) ES521728A0 (2)
FI (1) FI76092C (2)
GR (1) GR78582B (2)
HK (1) HK20588A (2)
HU (1) HU187068B (2)
IE (1) IE54628B1 (2)
IL (1) IL68453A (2)
NO (1) NO156202C (2)
NZ (1) NZ203988A (2)
PH (1) PH18035A (2)
PL (1) PL134978B1 (2)
PT (1) PT76587B (2)
SG (1) SG104087G (2)
SU (1) SU1138030A3 (2)
YU (1) YU43170B (2)
ZA (1) ZA832845B (2)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
WO1987002893A1 (en) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
EP0758651B1 (en) * 1994-05-02 2002-09-11 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
UA78104C2 (en) 2002-08-29 2007-02-15 Taisho Pharmaceutical Co Ltd Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives
JP5230934B2 (ja) * 2003-03-27 2013-07-10 バジリア ファルマスーチカ アーゲー 結晶形態のセファロスポリン
WO2005041925A2 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
CN101835750B (zh) 2007-08-22 2013-07-17 阿斯利康(瑞典)有限公司 环丙基酰胺衍生物
EP2220050A2 (en) 2007-10-26 2010-08-25 The Regents Of The University Of California Diarylhydantoin compounds as androgen receptor modulators
CA2750565C (en) * 2009-01-30 2015-10-20 Glaxosmithkline Llc Crystalline n-{(1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
KR20120079054A (ko) * 2009-07-10 2012-07-11 에볼바 아게 디인 조성물
JP5746718B2 (ja) * 2010-02-18 2015-07-08 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ シクロプロピルアミド誘導体からなる固体形態
US20110201623A1 (en) 2010-02-18 2011-08-18 Uczynski Michael A Crystalline Form Of A Cyclopropyl Benzamide Derivative
WO2014087972A1 (ja) * 2012-12-03 2014-06-12 株式会社カネカ 還元型補酵素ｑ10誘導体およびその製造方法
CN108484469A (zh) * 2013-09-05 2018-09-04 田边三菱制药株式会社 新型结晶性芳烷基胺化合物及其制造方法
KR102331856B1 (ko) 2014-10-21 2021-11-29 다케다 야쿠힌 고교 가부시키가이샤 결정 형태의 5-클로로-n4-[2-(디메틸포스포릴)페닐]-n2-｛2-메톡시-4-[4-(4-메틸피페라진-1-일)피페리딘-1-일]피리미딘-2,4-디아민
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
WO2017125557A1 (en) * 2016-01-22 2017-07-27 Sandoz Ag Crystalline eravacycline bis-hydrochloride
BR112019000293A2 (pt) * 2016-07-07 2019-04-16 Ironwood Pharmaceuticals, Inc. formas sólidas de um estimulador de sgc
EP3703686A4 (en) * 2017-10-30 2021-11-17 Theracaine LLC HYDROPHOBIC ARENE SULFONATE SALTS
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD994822S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD998740S1 (en) 2019-02-13 2023-09-12 Hs Produkt D.O.O. Firearm
USD994821S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1126349S1 (en) 2019-02-13 2026-05-12 Hs Produkt D.O.O. Firearm sight
USD1071069S1 (en) 2019-02-13 2025-04-15 Hs Produkt D.O.O. Stippled textured body for a firearm or the like
USD1057880S1 (en) 2019-08-09 2025-01-14 Hs Produkt D.O.O. Pistol
CA3207282A1 (en) * 2021-02-15 2022-08-18 Matthew J. Sharp Abiraterone prodrugs
EP4301749A1 (en) * 2021-03-01 2024-01-10 Orion Corporation Solid forms of a 4h-pyran-4-one structured cyp11a1 inhibitor
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol
WO2022237808A1 (zh) * 2021-05-12 2022-11-17 浙江龙传生物医药科技有限公司 吡咯并嘧啶类化合物的晶型及其制备方法
TW202311254A (zh) * 2021-05-14 2023-03-16 美商全球血液治療公司 血紅素之調節劑之固態形式
JP2024523518A (ja) * 2021-06-24 2024-06-28 サンド・アクチエンゲゼルシヤフト ソトラシブの結晶形態
USD1069964S1 (en) 2021-11-03 2025-04-08 Hs Produkt D.O.O. Pistol slide
US12410155B2 (en) * 2021-12-28 2025-09-09 Zhejiang Yangli Pharmaceutical Technology Co., Ltd. Salt form and crystal form of tetrahydrocyclohepta indazole compound
WO2023225678A2 (en) * 2022-05-20 2023-11-23 Caamtech, Inc. Tryptamine derivatives
USD1057882S1 (en) 2022-08-29 2025-01-14 Springfield, Inc. Combined serrations for a firearm slide
USD1072997S1 (en) 2022-08-29 2025-04-29 Springfield, Inc. Firearm
USD1061781S1 (en) 2022-11-30 2025-02-11 Hs Produkt D.O.O. Pistol
ZAA202301173S (en) 2023-04-28 2024-06-26 Hs Produkt D O O Firearm
WO2025016385A1 (en) * 2023-07-17 2025-01-23 Kura Oncology, Inc. Pharmaceutical compositions comprising a menin inhibitor
AU2024292586A1 (en) * 2023-07-17 2026-01-29 Kura Oncology, Inc. Crystalline forms of a menin inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
ZA80796B (en) * 1979-02-13 1981-02-25 Leo Pharm Prod Ltd Chemical compounds
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI76092C (fi) 1988-09-09
IL68453A0 (en) 1983-07-31
ZA832845B (en) 1984-11-28
KR860001279B1 (ko) 1986-09-05
IL68453A (en) 1986-08-31
CS235320B2 (en) 1985-05-15
ES8406075A1 (es) 1984-07-01
KR840004437A (ko) 1984-10-15
IE830926L (en) 1983-10-23
FI76092B (fi) 1988-05-31
US4432987A (en) 1984-02-21
DE3362502D1 (en) 1986-04-17
YU90483A (en) 1986-04-30
CA1187484A (en) 1985-05-21
EG16412A (en) 1989-03-30
ES521728A0 (es) 1984-07-01
SG104087G (en) 1988-07-15
EP0092968A1 (en) 1983-11-02
DK162168B (da) 1991-09-23
JPS58201792A (ja) 1983-11-24
IE54628B1 (en) 1989-12-20
YU43170B (en) 1989-04-30
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
HU187068B (en) 1985-11-28
JPH0119395B2 (2) 1989-04-11
SU1138030A3 (ru) 1985-01-30
DK101783A (da) 1983-10-24
FI831392A0 (fi) 1983-04-22
PT76587A (en) 1983-05-01
FI831392L (fi) 1983-10-24
GR78582B (2) 1984-09-27
DK101783D0 (da) 1983-02-28
DD209632A5 (de) 1984-05-16
PL241553A1 (en) 1983-11-21
NO156202C (no) 1987-08-19
HK20588A (en) 1988-03-25
DK162168C (da) 1992-03-02
PT76587B (en) 1986-02-27
EP0092968B1 (en) 1986-03-12
NO156202B (no) 1987-05-04
AU1387183A (en) 1983-11-17
PH18035A (en) 1985-03-06
PL134978B1 (en) 1985-09-30

Similar Documents

Publication Publication Date Title
AU1387183A (en) 1 1-dioxopenicillanoyl methyl penicillanate esters
AU543861B2 (en) Oltahydro-1h-indole-2-carboxylic acids
GB8326029D0 (en) Esters
GB8320518D0 (en) Cefuroxime ester
DE3361480D1 (en) Difluoromethoxyphenylthiophosphoric-acid esters
AU7702281A (en) 1-carboxy-azaalkanoylindoline-2-carboxylic acids
AU558627B2 (en) 2-oxo-1-azetidinesulphonic acids derivatives
AU2098183A (en) Atomizer
AU545463B2 (en) Benzoyl piperacine esters
AU564022B2 (en) Biotin esters
AU7192981A (en) N-acylated-n-methyl-carbamic acid-0-pyrazol-4-yl esters
AU538789B2 (en) 3-azidomethyl penicillin
AU537625B2 (en) Aryl-cyclopropane esters
AU535417B2 (en) Penicillanic acid esters
AU2138783A (en) Penicillins
MY8700194A (en) Carbamic-acid esters
AU558708B2 (en) 6-bromo-3-chloromethyl-3-methyl-penam-2-carboxylic acids
AU547381B2 (en) Penicillin derivative
AU559689B2 (en) Penicillin derivative
AU1308883A (en) Penicillins
GB8510717D0 (en) Ester
AU8440782A (en) Playing set
GB8323276D0 (en) 3-acylamino-2-oxo-1-azetidinyl esters
JPS57169461A (en) Phenoxypyridylmethyl esters
AU2253483A (en) Atomizer

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired